Skip to main content
. 2013 Dec 5;54(13):7952–7961. doi: 10.1167/iovs.13-12064

Figure 1.

Figure 1

Brain microglial activity post–GM-CSF administration. IBA1(+) cells are shown in yellow. (A) Vehicle-treated CNS. (B) GM-CSF-treated CNS. There is little difference in appearance or distribution in either treatment group. V, ventricle. Scale bar: 50 μm. (C) The CNS-microglial quantification. Little difference in microglial numbers is seen in either treatment group 7 days after administration, although there is a slight trend toward more microglia in the GM-CSF treatment group.